secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001171843-25-005288
Event type: debt
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Harvard Bioscience gets covenant waiver, interest rate jumps to SOFR+700bps; going concern doubt
--------------------------------------------------------------------------------

- Waived defaults for failing Q2 2025 financial covenants; no covenant test for Q3 2025.
- Interest rate increased to SOFR+700bps (ABR+650bps); $0.4M fee (1% of debt) payable.
- Must take steps toward refinancing by Dec 5, 2025 or face default; mandatory prepayment on refinancing/sale.
- Minimum liquidity of $3M required; company warns of substantial doubt about going concern.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325005288/0001171843-25-005288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184325005288/f8k_080825.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-005288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer